Table 3.
Comparing Proportion of Patients with Abnormal Lipid and Glucose Levels at Baseline and after 12 Months of ART
| No. (%) of patients with abnormal lipid levels |
|||||
| After 12 monthsof ART (n = 140) |
|||||
| Lipid parameters | Atbaseline (n = 140) | Total | Newly developed | Persisted from baseline | Pa |
| Total cholesterol level >200 mg/dL | 2 (1.4) | 37 (26) | 36 (26) | 1 | < .001 |
| Triglyceride level >150 mg/dL | 44 (31) | 45 (32) | 28 (20) | 17 (12) | .89 |
| HDL cholesterol level <40 mg/dL | 124 (91) | 31 (23) | 0 | 31 (23) | < .001 |
| LDL cholesterol level >130 mg/dL | 4 (3) | 32 (23) | 31 (23) | 1 | < .001 |
| Fasting blood glucose level >110 mg/dL | 19 (14) | 17 (13) | 15 (11) | 2 | .13 |
NOTE. ART, antiretroviral therapy.
Comparing the proportion of patients with abnormal lipid levels at baseline and at 12 months with use of McNemar test.